The World Health Organisation (WHO) has approved a COVID-19 vaccine made by Sinovac Biotech for emergency use listing.
It's the second Chinese-produced shot to get its endorsement, a WHO statement said on Tuesday.
WHO emergency listing is a signal to national regulators on a product's safety and efficacy.
It would also allow the shot to be included in COVAX, the global programme to provide vaccines mainly for poor countries, which currently faces major supply problems.
In a statement, the independent panel of experts said it recommended Sinovac's vaccine for adults over 18, with a second dose 2-4 weeks later.
There was no upper age limit as data suggested it is likely to have a protective effect in older people.
UK to recognise Palestinian state in September unless Israel takes action
Gaza death toll hits 60,000 as global monitor demands action to avert famine
Gunman kills four in Manhattan skyscraper, then takes own life
India says forces killed 3 'terrorists' behind Kashmir attack
GCC welcomes efforts for two-state solution amid Saudi-French conference
Thailand-Cambodia border calm as military commanders hold talks
Trump says many are starving in Gaza, vows to set up food centres
Extreme weather turns Beijing into rain trap, kills at least 30
